Prevention of the degeneration of human dopaminergic neurons in an astrocyte co‐culture system allowing endogenous drug metabolism

Few neuropharmacological model systems use human neurons. Moreover, available test systems rarely reflect functional roles of co‐cultured glial cells. There is no human in vitro counterpart of the widely used 1‐methyl‐4‐phenyl‐tetrahydropyridine (MPTP) mouse model of Parkinson's disease

[1]  J. Langston,et al.  Can cellular models revolutionize drug discovery in Parkinson's disease? , 2009, Biochimica et biophysica acta.

[2]  M. Leist,et al.  Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. , 2012, Neurotoxicology.

[3]  C. Olanow,et al.  Modeling Parkinson's disease , 2009, Annals of neurology.

[4]  Nicola J. Allen,et al.  Neuroscience: Glia — more than just brain glue , 2009, Nature.

[5]  L. Costa,et al.  Morphological Assessment of Neurite Outgrowth in Hippocampal Neuron‐Astrocyte Co‐Cultures , 2012, Current protocols in toxicology.

[6]  M. Memo,et al.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.

[7]  D. Guastella,et al.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Hui Ge,et al.  Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease , 2013, PloS one.

[9]  L. Tönges,et al.  Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease , 2012, Brain : a journal of neurology.

[10]  M. Rao,et al.  Using Human Pluripotent Stem Cell–Derived Dopaminergic Neurons to Evaluate Candidate Parkinson’s Disease Therapeutic Agents in MPP+ and Rotenone Models , 2013, Journal of biomolecular screening.

[11]  Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease , 2007, Neurology.

[12]  H. Kang,et al.  Poly (ADP-ribose) in the pathogenesis of Parkinson's disease , 2014, BMB reports.

[13]  P. Nicotera,et al.  ATP Controls Neuronal Apoptosis Triggered by Microtubule Breakdown or Potassium Deprivation , 1999, Molecular medicine.

[14]  L. Vécsei,et al.  Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection , 2011, CNS neuroscience & therapeutics.

[15]  M. A. Ajmone-Cat,et al.  Astrocytes contribute to neuronal impairment in βA toxicity increasing apoptosis in rat hippocampal neurons , 2001, Glia.

[16]  E. Cacci,et al.  In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia , 2008, Glia.

[17]  D. Standaert,et al.  Targets for neuroprotection in Parkinson's disease. , 2009, Biochimica et biophysica acta.

[18]  D. Krainc,et al.  Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.

[19]  Huidong Yu,et al.  Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP⁺-induced oxidative stress and cell death in SH-SY5Y cells. , 2014, Free radical biology & medicine.

[20]  P. Mcgeer,et al.  Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis , 2015, Neurobiology of Aging.

[21]  Robert E. Burke,et al.  Axon degeneration in Parkinson's disease , 2013, Experimental Neurology.

[22]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[23]  Adam J Pawson,et al.  The Concise Guide to Pharmacology 2013/14: Enzymes , 2013, British journal of pharmacology.

[24]  T. Dawson,et al.  Parthanatos Mediates AIMP2 Activated Age Dependent Dopaminergic Neuronal Loss , 2013, Nature Neuroscience.

[25]  Tanja Waldmann,et al.  Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line , 2011, Journal of neurochemistry.

[26]  Jeppe Falsig,et al.  Specific Modulation of Astrocyte Inflammation by Inhibition of Mixed Lineage Kinases with CEP-13471 , 2004, The Journal of Immunology.

[27]  G. Miller,et al.  Industrial toxicants and Parkinson's disease. , 2012, Neurotoxicology.

[28]  M. Beal,et al.  NOS knockouts and neuroprotection , 1999, Nature Medicine.

[29]  D. B. Tower,et al.  THE ACTIVITIES OF BUTYRYLCHOLINESTERASE AND CARBONIC ANHYDRASE, THE RATE OF ANAEROBIC GLYCOLYSTS, AND THE QUESTION OF A CONSTANT DENSITY OF GLIAL CELLS IN CEREBRAL CORTICES OF VARIOUS MAMMALIAN SPECIES FROM MOUSE TO WHALE , 1973, Journal of neurochemistry.

[30]  J. Cadet,et al.  An In Vitro Model of Human Dopaminergic Neurons Derived from Embryonic Stem Cells: MPP+ Toxicity and GDNF Neuroprotection , 2006, Neuropsychopharmacology.

[31]  K. McNaught,et al.  Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures , 1999, Journal of neurochemistry.

[32]  A. Henn,et al.  Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions. , 2012, ALTEX.

[33]  Dorit Merhof,et al.  Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants , 2013, Archives of Toxicology.

[34]  P. Brundin,et al.  A simple method for large‐scale generation of dopamine neurons from human embryonic stem cells , 2010, Journal of neuroscience research.

[35]  J. Pocock,et al.  Microglial secreted cathepsin B induces neuronal apoptosis , 2001, Journal of neurochemistry.

[36]  Jeppe Falsig,et al.  Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway , 2005, The Journal of Neuroscience.

[37]  J. Langston,et al.  MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. , 1984, Acta neurologica Scandinavica. Supplementum.

[38]  M. Smeyne,et al.  Strain‐dependent susceptibility to MPTP and MPP+‐induced Parkinsonism is determined by glia , 2001, Glia.

[39]  P. Nicotera,et al.  1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. , 1998, Molecular pharmacology.

[40]  L. Greene,et al.  ATF4 Protects Against Neuronal Death in Cellular Parkinson's Disease Models by Maintaining Levels of Parkin , 2013, The Journal of Neuroscience.

[41]  M. Youdim.  Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents , 2010, Experimental neurobiology.

[42]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[43]  N. Neff,et al.  CEP‐1347 (KT7515), an Inhibitor of JNK Activation, Rescues Sympathetic Neurons and Neuronally Differentiated PC12 Cells from Death Evoked by three Distinct Insults , 1999, Journal of neurochemistry.

[44]  Marcel Leist,et al.  Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. , 2013, ALTEX.

[45]  K. Frei,et al.  Macrophage‐induced cytotoxicity of N‐methyl‐D‐aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines , 1992, European journal of immunology.

[46]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands , 2013, Nucleic Acids Res..

[47]  T Hartung,et al.  Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP+ , 2014, Cell Death and Disease.

[48]  P. Popovich,et al.  Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis , 2014, Neuron.

[49]  H. Reichmann,et al.  Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice , 2012, Scientific Reports.

[50]  Guy C. Brown,et al.  Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity , 2001, The Journal of Neuroscience.

[51]  M. Scheffner,et al.  Poly(ADP‐ribose)‐mediated interplay of XPA and PARP1 leads to reciprocal regulation of protein function , 2014, The FEBS journal.

[52]  Florian Gantner,et al.  Phagocytosis of Nonapoptotic Cells Dying by Caspase- Independent Mechanisms1 , 2000, The Journal of Immunology.

[53]  P. Mcgeer,et al.  Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[54]  Thomas Gasser,et al.  Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling , 2013, PloS one.

[55]  Paola Piccini,et al.  Priorities in Parkinson's disease research , 2011, Nature Reviews Drug Discovery.

[56]  P. Schwartz,et al.  Human Pluripotent Stem Cells , 2011, Methods in Molecular Biology.

[57]  W. Koh,et al.  Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing , 2011, Cell Death and Differentiation.

[58]  A. Bürkle,et al.  Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells. , 2010, Biochemical pharmacology.

[59]  N. Neff,et al.  Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives. , 1997, Journal of medicinal chemistry.

[60]  J. Schulz,et al.  Inhibition of Neuronal Nitric Oxide Synthase by 7‐Nitroindazole Protects Against MPTP‐Induced Neurotoxicity in Mice , 1995, Journal of neurochemistry.

[61]  Adam J Pawson,et al.  The Concise Guide to Pharmacology 2013/14: Transporters , 2013, British journal of pharmacology.

[62]  L. Costa,et al.  Astrocytes protect against diazinon- and diazoxon-induced inhibition of neurite outgrowth by regulating neuronal glutathione. , 2014, Toxicology.

[63]  Jeppe Falsig,et al.  Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95‐driven apoptosis , 2003, Journal of neurochemistry.

[64]  V. Tabar,et al.  Derivation of midbrain dopamine neurons from human embryonic stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[65]  T. Sugimura,et al.  Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. , 1984, Biochemistry.

[66]  T. Südhof,et al.  Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.

[67]  M. Leist,et al.  Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. , 2009, Toxicology and applied pharmacology.

[68]  Scott A Noggle,et al.  Differentiation of Human Embryonic Stem Cells to Dopaminergic Neurons in Serum‐Free Suspension Culture , 2004, Stem cells.

[69]  M. Fan,et al.  Generation of dopaminergic neurons from human fetal mesencephalic progenitors after co-culture with striatal-conditioned media and exposure to lowered oxygen , 2009, Brain Research Bulletin.